期刊文献+

高效液相色谱法测定盐酸丙酰左卡尼汀片中盐酸丙酰左卡尼汀的含量

Determination of the content of propionyl L-carnitine hydrochloride in propionyl L-carnitine hydrochloride tablets by HPLC
下载PDF
导出
摘要 目的建立高效液相色谱法(HPLC)用于测定盐酸丙酰左卡尼汀片中盐酸丙酰左卡尼汀的含量。方法色谱柱为Thermo Hypersil Aps-2氨基柱(4.6 mm×250 mm,5μm),流动相为0.05 mol·L^(-1)磷酸二氢钾缓冲液-乙腈(35∶65),流速1.0 mL·min^(-1),柱温30℃,检测波长205 nm。结果盐酸丙酰左卡尼汀在0.505 0~5.050 2 g·L^(-1)(r=0.9999)浓度范围内线性良好,平均加样回收率为100.1%。结论该文建立的方法专属性强、重复性好、结果准确可靠,可用于盐酸丙酰左卡尼汀片的质量控制和评价。 Objective To establish an HPLC method for determining the content of propionyl L-carnitine hydrochloride in propionyl Lcarnitine hydrochloride tablets. Methods The column was on a Thermo Hypersil Aps-2 amino column( 4. 6 mm × 250 mm,5 μm) and0. 05 mol·L^-1 solution of potassium dihydrogen phosphate-acetonitrile( 35∶ 65) was employed as the mobile phase. The flow rate was1. 0 mL·min^-1 with UV detection wavelength at 205 nm and the column temperature was kept at 30℃. Results The linear range of propionyl L-carnitine hydrochloride was within 0. 505 0 and 5. 050 2 g·L^-1( r = 0. 999 9). The average recovery was 100. 1%. Conclusion The method is of high specificity,repeatability and accuracy,and it can be used for the quality control and evaluation of propionyl-L-carnitine hydrochloride tablets.
作者 肖红梅 XIAO Hongmei(Department of Pharmacy,The First Affiliated Hospital of Anhui Medical University,The Grade3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine,Hefei,Anhui 230001,China)
出处 《安徽医药》 CAS 2018年第11期2099-2101,共3页 Anhui Medical and Pharmaceutical Journal
关键词 氯丙酰左卡尼汀片 高效液相色谱法 含量测定 Propionyl L-earnitine hydroehloride tablets HPLC Content determination
  • 相关文献

参考文献8

二级参考文献86

  • 1Loffredo L, Pignatelli P, Cangemi R, et al. Imbalance between nitric oxide generation and oxidative stress in patients with peripheral arterial disease: effect of an antioxidant treatment[J].J Vasc Surg, 2006,44(3):525-530.
  • 2Allegra C, Antignani PL, Schachter I, et al. Propionyl-L-carnitine in Leriche-Fontaine stage Ⅱ peripheral arterial obstructive disease[J]. Ann Vasc Surg,2008,22(4):552-558.
  • 3Hiatt WR, Regensteiner JG, Creager MA,et al. Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication[J].Am J Med,2001,110(8):616-622.
  • 4Barker GA, Green S, Askew CD, et al. Effect of propionyl-L-camitine on exercise performance in peripheral arterial disease[J]. Med Sci Sports Exert, 2001,33(9): 1415 - 1422.
  • 5Smith WA, Fry AC, Tscbume LC, et al. Effect of glycine propionyl- L-camitine on aerobic and anaerobic exercise performance[J]. Int J Sport Nutr Exerc Metab, 2008,18(1): 19-36.
  • 6Riccioni C, Sarcinella R, Palermo G, et al. Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriehe stage Ⅱ[J].Int Angiol, 2008,27(3):253-259.
  • 7zzollini N, Cugini D, Cassis P, et al. Propionyl-L-carnitine prevents early graft dysfunction in allogeneic rat kidney transplantation[J]. Kidney Int, 2008,74(11): 1420-1428.
  • 8Origlia N, Migliori M, Panichi V, et al. Protective effect of L-propionylcamitine in chronic cyclosporine-a induced nephrotoxicity[J]. Biorned Pharmacother, 2006,60(2):77-81.
  • 9Aleisa AM, Al-Majed AA, Al-Yahya AA, et al. Reversal of cisplatininduced carnitine deficiency and energy starvation by propionyl- L-carnitine in rat kidney tissues.[J] Clin Exp Pharmacol Physiol, 2007,34(12): 1252-1259.
  • 10Broderick TL.ATP production and TCA activity are stimulated by propionyl-L-carnitine in the diabetic rat heart[J]. Drugs R D, 2008,9(2):83-91.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部